What to know about retatrutide
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gounder has the latest.
Weight Loss
Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
Experimental weight loss drug sold illegally
Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lilly, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found. CBS News investigative reporter and producer Daniel Gilbert has the story.
Access expanding for experimental weight loss drug
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safety, who is eligible for the medication and more.
GLP-1s are linked to a 17% drop in worker sick leave, new study finds
Here's how weight-loss drugs like Ozempic and Wegovy could reduce worker illness and save companies money.
Novo Nordisk sues Eli Lilly, accusing it of false advertising
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.
Here's what to know about Medicare's new GLP-1 weight-loss drug program
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.
Extreme heat and GLP-1 drugs
More than 10% of Americans say they use GLP-1 drugs. But experts warn some side effects from the drugs could lead to dehydration, especially in extreme heat. Nutritionist Keri Glassman explains.
Benefits and risks of GLP-1 drugs for kids
Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.
Weight loss drug use during pregnancy
CBS News medical correspondent Dr. Celine Gounder breaks down findings from a new study that takes a close look at popular GLP-1 weight loss drugs and their use during early pregnancy.
Safety concerns over weight loss drug
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
Doctors promote experimental weight loss drug
The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors from offering it, and it could come with serious side effects. Adam Yamaguchi reports.
How an experimental weight-loss drug is being openly promoted by physicians
Doctors are jumping the gun to prescribe a medication lacking FDA approval that has gone viral on social media. "Why are we waiting?" one physician asked.
New study on weight loss drugs, breast cancer
Researchers from Penn Medicine found women taking GLP-1 drugs are less likely to be diagnosed with breast cancer. Dr. Celine Gounder breaks down the study's findings and if the drugs caused the difference.
New weight-loss drug Retatrutide in trials
A new weight-loss drug, so new it is not on the market yet, is showing promising results in trials, doing much more than what current medications can. Dr. Jon LaPook breaks it down.
Impact of GLP-1 drugs on diet culture
Outspoken body acceptance advocate Katie Sturino, who is the founder of Megababe Beauty, explains why it was a difficult decision for her to start taking weight loss drugs. She's joined by psychiatrist Dr. Sue Varma who breaks down what people should do before taking a GLP-1 and the impact of societal pressure.
FDA approves new weight loss pill
The FDA has approved a pill from Eli Lilly that could change how millions of Americans take medications to lose weight. The drug is the second GLP-1 pill approved by federal regulators for weight loss and the first that doesn't require fasting or meal timing. Dr. Celine Gounder breaks down what to know about accessibility and cost.
FDA approves Eli Lilly weight loss pill
The FDA approved a new GLP-1 drug from Eli Lilly. Dr. Jon LaPook breaks it down.
Weight loss drugs could save airlines money on fuel as Americans shed pounds
As obesity rates among Americans drop and weight loss drugs lead to a slimmer society, airlines could save on fuel costs, according to a recent analysis.
"Enough": Oprah Winfrey on her weight-loss lessons
For years, she seemed powerless against a fluctuating weight problem, until new medications, and a new attitude, gave Oprah Winfrey a breakthrough. She talks with Jane Pauley about "Enough," a new book co-written with Dr. Ania Jastreboff, about her weight-loss success.
Book excerpt: "Enough" by Dr. Ania Jastreboff and Oprah Winfrey
The media superstar, who has struggled with weight for much of her life, and a Yale School of Medicine doctor team up for a book that examines the biology of obesity, offering a new way forward.
"Enough": Oprah Winfrey on her weight-loss lessons
Oprah Winfrey is one of the best-known, most-admired and successful people on the planet. But for years she seemed powerless to conquer her fluctuating weight problem … until new medications, and a new attitude about her weight, gave her a breakthrough, which she describes in "Enough," a new book she has co-written with Dr. Ania Jastreboff. They talk with Jane Pauley about an individual's genetically-influenced weight range, and how to reset it. Winfrey also relates the long road she traveled since she began her TV career in Nashville, facing sexism, racism, and comments about her weight.
New study on stopping weight loss drugs
Popular weight loss drugs like GLP-1 injections are helping millions of people lose pounds. But a new study shows that stopping these medications can cause the weight to rapidly come back and reverse positive health effects. CBS News medical contributor Dr. Céline Gounder has more.
Impact of stopping use of weight loss drugs
New research suggests that after stopping the use of weight loss drugs, weight regain is almost four times faster compared to after traditional diet and physical exercise programs. CBS News medical contributor Dr. Celine Gounder explains what the study found.
Trump says he'll start paying for ads after pushback over taxpayer funding
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump suggests letting Iran "take out" LA, San Diego during rally
Live
Battle with Iran-backed Houthis in Yemen tempers news on oil flow
Ex-"American Idol" contestant Caleb Flynn gets life sentence
Chicago-bound flight drops 27,000 feet, returns to London
Alleged Chinese agent makes federal court appearance
Only On CBS
Takeaways from Alito's CBS News interview
